Your browser doesn't support javascript.
loading
Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical Trial.
Gastaminza, Gabriel; Azofra, Julian; Nunez-Cordoba, Jorge M; Baeza, Maria Luisa; Echechipía, Susana; Gaig, Pere; García, Blanca Esther; Labrador-Horrillo, Moises; Sala-Cunill, Ana; Brescó, Marina Sabaté; Beristain, Ana; Quiñones, Dolores; Donado, Carmen Díaz; Zubeldia, José Manuel; Ferrer, Marta.
Afiliação
  • Gastaminza G; Department of Allergy and Clinical Immunology, Clinica Universidad de Navarra, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain; RETIC de Asma, Reacciones adversas y Alérgicas (ARADYAL), Madrid, Spain.
  • Azofra J; Allergy Section, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Nunez-Cordoba JM; Clínica Universidad de Navarra, Research Support Service, Central Clinical Trials Unit, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
  • Baeza ML; Allergy Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Biomedical Research Network on Rare Diseases (CIBERER)-U761, Madrid, Spain; Gregorio Marañón Health Research Institute, Madrid, Spain.
  • Echechipía S; Allergy Service, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Gaig P; Allergy Section, Hospital Universitari Joan XXIII de Tarragona, Tarragona, Spain; Departament de Medicina i Cirurgia, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Tarragona, Spain.
  • García BE; RETIC de Asma, Reacciones adversas y Alérgicas (ARADYAL), Madrid, Spain; Allergy Service, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Labrador-Horrillo M; RETIC de Asma, Reacciones adversas y Alérgicas (ARADYAL), Madrid, Spain; Allergy Section, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Sala-Cunill A; RETIC de Asma, Reacciones adversas y Alérgicas (ARADYAL), Madrid, Spain; Allergy Section, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Brescó MS; Department of Allergy and Clinical Immunology, Clinica Universidad de Navarra, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain; RETIC de Asma, Reacciones adversas y Alérgicas (ARADYAL), Madrid, Spain.
  • Beristain A; Allergy Section, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Quiñones D; Allergy Section, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Donado CD; Allergy Section, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Zubeldia JM; Allergy Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Biomedical Research Network on Rare Diseases (CIBERER)-U761, Madrid, Spain; Gregorio Marañón Health Research Institute, Madrid, Spain.
  • Ferrer M; Department of Allergy and Clinical Immunology, Clinica Universidad de Navarra, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain; RETIC de Asma, Reacciones adversas y Alérgicas (ARADYAL), Madrid, Spain. Electronic address: mferrerp@unav.es.
J Allergy Clin Immunol Pract ; 7(5): 1599-1609.e1, 2019.
Article em En | MEDLINE | ID: mdl-30654196
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article